Those who invested in S&T Bancorp (NASDAQ:STBA) five years ago are up 106% - Yahoo Finance2 weeks ago • Google News
Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients - PR Newswire2025-06-15 • Google News